Tricuspid valve disease

Definition

This chapter discusses regurgitation and stenosis of the tricuspid valve (TV) in those uncommon situations in which it occurs as an isolated lesion, as well as TV disease associated with mitral or combined mitral and aortic valve disease. Mitral valve surgery with coexisting TV disease is also discussed in Chapter 11 .

TV abnormalities or disease may be associated with various conditions discussed in other chapters, including atrioventricular (AV) septal defect ( Chapter 32 ), ventricular septal defect with straddling TV ( Chapter 33 ), pulmonary atresia and intact ventricular septum ( Chapter 36 ), Ebstein anomaly ( Chapter 48 ), and right atrial myxoma ( Chapter 17 ). Rarely, isolated TV disease is secondary to traumatic injury, inferior myocardial infarction, , administration of methysergide or pergolide, , scleroderma, lupus erythematosus, primary phospholipid syndrome, hypereosinophilic syndrome, and carcinoid heart disease.

Functional (secondary) tricuspid regurgitation

The multitude of chordal attachments of the TV, described in Chapter 1 , may impair proper leaflet coaptation and promote tricuspid regurgitation (TR) in the presence of right ventricular (RV) dysfunction and dilation. The tricuspid anulus shortens during systole when the TV is competent. , When RV dilation develops, usually as a consequence of important disease of the left-sided heart valves in association with pulmonary arterial hypertension, the tricuspid anulus also dilates (lengthens) and fails to shorten during systole. The leaflets and chordae remain normal in appearance. The septal leaflet portion of the anulus lengthens least in this process because it is fixed between the right and left trigones and the atrial and ventricular septa. As the RV free wall dilates, the remaining two-thirds of the anulus lengthens, particularly that part giving origin to the posterior leaflet ( Fig. 13.1 ). , , The anular dilation results in failure of leaflet coaptation, which is contributed to in some patients by chordal shortening secondary to the RV dilation. Thus, a strong correlation exists between tricuspid anular diameter measured echocardiographically and presence and severity of TR ( Fig. 13.2 ). As the tricuspid anulus dilates, it assumes a more circular shape in a flat plane. The reported threshold for TR based on anular dilation is 27 mm · m2 or about 34 mm in the average adult.

• Figure 13.1

Dilation of the TV anulus, indicated by a sequence of overlaid annuli. Tricuspid anular dilation due to increased RV and pulmonary artery pressures secondary to left-sided heart valve disease occurs predominantly in the septal-lateral direction, as indicated by arrows.

• Figure 13.2

Correlation between tricuspid anulus diameter (TAD) and tricuspid regurgitant volume (V TR ) in patients with valvular heart disease ( open circles ) and those with atrial septal defect ( closed circles ). Correlation with the former is 0.87 and with the latter, 0.88. Correlation lines cross the horizontal axis at a TAD of 33 to 34 mm, which is the threshold for TR in adult patients. ASD, Atrial septal defect; VHD, valvular heart disease.

The degree of TR is also importantly influenced by RV preload, afterload, and systolic function because the tricuspid anulus is very dynamic, with a 15% to 20% reduction in circumference during atrial systole. , ,

Early experimental work by Tsakiris and colleagues showed that perfect systolic tricuspid leaflet closure depends on proper systolic shortening in the circumference of the tricuspid anulus. , In support of this finding, Simon and colleagues demonstrated a considerable increase in systolic shortening postoperatively in patients whose TR lessens after mitral valve surgery and no change in those in whom it persists or worsens. In addition, increased diastolic diameter of the tricuspid anulus results in TR; diastolic diameter is increased by pulmonary artery hypertension, RV myocardial failure, and increased diastolic volume secondary to left-sided heart pathology.

The pathogenesis of functional TR in mitral valve disease is summarized in Fig. 13.3 . The final common pathway is RV dysfunction and dilation and tricuspid anular dilation. The process becomes self-propagating because worsening TR exacerbates RV volume overload with further RV dysfunction and enlargement. In addition, because of ventricular interdependence, worsening RV dysfunction increases interventricular shift toward the left, causing restricted left ventricular filling, further elevation of left atrial pressure, pulmonary hypertension, and greater RV afterload, which further affects the right ventricle.

• Figure 13.3

Pathogenesis of TR in mitral valve disease. DCM, dilated cardiomyopathy; RHD, rheumatic heart disease; RV, right ventricle; TV, tricuspid valve.

(Redrawn from Shiran A, Sagie A. Tricuspid regurgitation in mitral valve disease incidence, prognostic implications, mechanism, and management. J Am Coll Cardiol . 2009;53:401-408.)

It is these mechanisms that may produce TR late after isolated mitral valve operations or after combined aortic and mitral valve operations (see Chapters 11 and 12 ).

Rheumatic tricuspid stenosis and regurgitation

Rheumatic TV disease occurs in association with rheumatic involvement of the mitral valve, the mitral and aortic valves combined, or rarely, the aortic valve alone. It is not seen as an isolated lesion.

Rheumatic tricuspid disease usually results in a regurgitant valve with variable amounts of stenosis, but in rare cases, there may be pure stenosis. In tricuspid stenosis, the orifice is larger than in mitral stenosis, even when hemodynamically there is severe obstruction. Therefore, the hemodynamic effects of anatomically moderate tricuspid stenosis are the equivalent of tight mitral stenosis. A mean diastolic gradient of even 4 to 5 mmHg across the TV indicates important stenosis. Borders of the stenotic tricuspid orifice are usually fibrous and thickened, although peripheral portions of the leaflets remain thin.

The hallmark of organic tricuspid stenosis is commissural fusion. All commissures are usually equally fused, but occasionally, fusion is limited to the anteroseptal commissure. Chordal thickening and fusion are usually mild, and calcification is usually absent.

Tricuspid valve endocarditis

Acute TV endocarditis is rapidly increasing in frequency and is usually associated with intravenous drug use or long-term indwelling catheters. The most common etiologic organism is Staphylococcus aureus in drug-use patients, with coagulase-negative Staphylococcus being more common in patients with indwelling catheters. A variety of gram-negative bacilli or Candida albicans can rarely be the infective organism. The organisms may form masses on the valve leaflets or erode and destroy large portions of leaflets and chordae (see Chapter 14 ).

Traumatic injury of tricuspid valve

TR is an uncommon result of severe, nonpenetrating chest injury and, in this setting, is due to rupture of one or more papillary muscles or chordae (see “ Atrioventricular Valve Rupture ” in Section II of Chapter 16 ). Usually, it is the anterior tricuspid leaflet that becomes flail. Rarely, the ventricular septum may rupture.

Injury of the TV due to a transvenous ventricular lead of a cardiac implantable electronic device (CIED) or its removal is occasionally associated with important TR. This may be due to perforation, laceration, or scarring for indwelling leads or avulsion in the case of lead removal. Rarely, CIED leads can cause tricuspid stenosis secondary to leaflet scarring and adhesions. Similar scarring of the septal and posterior leaflets following cryothermic or radiofrequency ablative procedures rarely can produce severe TR. Following cardiac transplantation, many years of repeated transvenous endomyocardial biopsies may induce severe TR secondary to inadvertent severing of chordae during biopsy.

Carcinoid tricuspid valve disease

Carcinoid tumors originate from Kulchitsky cells in the gastrointestinal tract, which produce serotonin (5-hydroxytryptamine), a substance inactivated in the liver. However, carcinoid tumors that metastasize to the liver produce serotonin there, and this powerful substance passes into the pulmonary and, to a lesser extent, systemic circulation. Thereby, carcinoid syndrome may be produced with bronchospasm, diarrhea, nausea, malabsorption, flushing, and telangiectasia. In some of these patients, cicatricial deformity of the tricuspid and pulmonary valves also develops.

Typical carcinoid symptoms are considerably more common in carcinoid patients with valvar involvement than in noncardiac carcinoid patients. Tricuspid commissures are fused, chordae tendineae thickened and fused, and leaflets thickened and shortened, resulting in regurgitation and in some patients a mild degree of stenosis. Microscopically, a deposition of loose or compact fibrous tissue is present on both surfaces of the tricuspid leaflets. The white fibrous plaques, if present on the ventricular side of the leaflets, promote adherence of the leaflet to the underlying ventricular myocardium, preventing appropriate leaflet coaptation.

TR is the most common cardiac manifestation of carcinoid syndrome and is managed surgically by TV replacement, usually with a bioprosthesis. Concomitant pulmonary valve replacement is necessary in approximately 85% of patients. Perioperative mortality of valve replacement for carcinoid heart disease is acceptably low in the current era (5%), but early and late mortality is closely related to the degree of preoperative disability and right heart failure as reflected by New York Heart Association (NYHA) functional class. Furthermore, patients should be monitored closely postoperatively because of a high incidence of bioprosthetic valve degeneration.

Clinical features and diagnostic criteria

TV disease affects approximately 0.8% of the US population, compared to 2.4% having mitral valve prolapse. About 8000 persons per year undergo TV surgery in the United States.

Tricuspid stenosis

Moderate degrees of tricuspid stenosis may be overlooked, particularly if the patient is in atrial fibrillation. If sinus rhythm is present, there is a dominant a wave in the jugular venous pulse (immediately preceding the carotid pulse). Other signs include a mid-diastolic, often high-pitched murmur maximal over the lower left sternal edge, which increases on inspiration; there may be a tricuspid opening snap. The murmur can be confused with an aortic early diastolic murmur (because its timing may be relatively early) or with a conducted mitral diastolic murmur. The liver is usually enlarged but not pulsatile (unless from forceful atrial contraction that produces a presystolic pulse).

The chest x-ray shows right atrial enlargement, and in the presence of sinus rhythm, the electrocardiogram shows a prominent P wave. Two-dimensional (2D) echocardiography is helpful in establishing the presence of leaflet thickening and mobility. Doppler echocardiography helps quantify the valve area and transvalvular gradient. There is no general consensus on the grading of tricuspid stenosis severity, but a TV area <1.0 cm 2 and a mean transvalvular gradient >5 mmHg at normal heart rate are indicative of significant tricuspid stenosis.

Tricuspid regurgitation

History and physical signs are often highly suggestive of significant TR. The jugular venous pulse shows dominant fused c and v waves, followed by a sharp, deep y descent. The murmur, maximal over the lower left sternal edge, is pansystolic, often high pitched, and increases on inspiration. However, when TR is severe, a murmur may be absent. The enlarged liver shows systolic pulsation. In advanced cases, there are other signs of right heart failure, including peripheral edema and ascites. Concomitant mitral or aortic valve disease occurs frequently, and severe right heart failure may occur under such conditions without TR.

Severe TR is generally manifested by progressive fatigue and weakness related to reduction in cardiac output and the unpleasant sensation of ascites, congestive hepatosplenomegaly, and peripheral edema. These symptoms are related to heart failure and volume overload and can be palliated with aggressive diuretic therapy. In the chronic stages, however, symptoms become refractory, and cachexia and jaundice may be present.

Quantification of the degree of TR is important when interventional treatment is being considered, but preoperative assessment is often difficult because of the confounding effect of severe cardiac failure. In this regard, 2D echocardiography and cardiac magnetic resonance (CMR) are particularly useful.

Echocardiography is the preferred method to evaluate TR. In the more uncommon primary TR, specific abnormalities of the leaflets or the subvalvular apparatus can be identified. In secondary TR, anular dilation along with increased RV and right atrial dimensions are typically observed. RV function should be assessed, given its prognostic relevance. RV strain and three-dimensional (3D) measurements of RV volumes are helpful in overcoming the limitations of conventional RV function indexes.

Echocardiographic evaluation of TR severity is based on multiple parameters, including (1) qualitative: color flow regurgitant jet and valve morphology; (2) semiquantitative: vena contracta and proximal isovelocity surface area (PISA) radius; and (3) quantitative: effective regurgitant orifice area (EROA), regurgitant volume, and size of the right cardiac chambers/vena cava. In addition, pulmonary pressures can be estimated using Doppler gradients. However, this may not be possible or might underestimate the severity of pulmonary hypertension in the presence of severe TR. Hence, in the presence of severe TR and suspected pulmonary hypertension, right cardiac catheterization is the method of choice to evaluate pulmonary vascular resistance.

In addition to echocardiography, CMR is a highly accurate and reproducible method to assess RV function, dimensions, and morphology, but its availability may be limited. CMR is also a helpful tool to calculate the tricuspid regurgitant volume by means of RV volumetry. ,

The classical quantification of TR included mild, moderate, and severe degrees. Recently, a new grading scheme including two additional degrees (“massive” and “torrential”) has been proposed and implemented in clinical studies on transcatheter interventions. , Including the two additional grades of TR has shown an improved predictive value in terms of mortality and rehospitalization for heart failure, especially in patients with advanced disease. , Assessment of TR may be dynamic, and the decision for intervention is best made based on preoperative assessment. Moderate and severe TR grades have a fair agreement between preoperative transthoracic echocardiography (TTE) and intraoperative transesophageal echocardiography (TEE) assessment, but mild TR on preoperative TTE is often downgraded to minimal TR on intraoperative assessment. In contrast, there is reasonably good correlation between anulus diameter measurements from preoperative TTE and intraoperative TEE images.

In the special setting of TV endocarditis in intravenous drug users, the valve is usually rapidly destroyed, and classic signs and symptoms of severe TR may develop very precipitously. The illness is usually only a few weeks in duration before the patient presents for medical care. Frequently, pulmonary symptoms and signs secondary to septic pulmonary emboli are marked. The diagnosis can be strongly suspected from a history of drug abuse, evidence of pulmonary infection, elevated jugular venous pressure, pulsatile neck veins, and pulsatile liver. These features, combined with positive blood cultures and echocardiography, are usually sufficient to establish the diagnosis.

Diagnosis of traumatic TR is usually easily established by signs of severe TR and a history of chest trauma. Occasionally, however, the relationship of these signs to a history of injury is not obvious. In patients with traumatic TR, right-to-left shunting may occur across a patent foramen ovale.

Natural history

The natural history of patients with dominantly stenotic TV disease is usually determined primarily by associated rheumatic mitral or aortic valve disease. The increased systemic venous pressure, hepatomegaly, and peripheral edema, however, accelerate deterioration of patients with rheumatic tricuspid stenosis.

Primary TR has an inherent tendency to progress, just as do other types of valvular regurgitation. However, the deleterious effects of RV volume overload are slower to develop than those of the left ventricle. For example, in patients with traumatic TR who survive the initial trauma, regurgitation may be well tolerated for many months or years. , Ultimately, however, symptoms develop as TR leads to RV volume overload and dilation, thereby increasing TR in a positive feedback loop. In a study of 60 patients with severe organic TR secondary to trauma, myxomatous change, or endocarditis, those who did not undergo operation had an increased risk of heart failure, atrial fibrillation, and death ( Fig. 13.4 ).

• Figure 13.4

Natural history after occurrence of TR caused by flail leaflets in patients without associated diseases contributing to symptoms (Sx). Kaplan-Meier curves depict occurrence of new atrial fibrillation (AF; 2.8% yearly), NYHA functional class III or IV symptoms, or heart failure (HF) (Sx or HF; 4.4% yearly) and composite endpoint of first occurrence of Sx or HF, new AF, tricuspid surgery, or death (6.5% yearly).

(From Bruce CJ, Connolly HM. Right-sided valve disease deserves a little more respect. Circulation . 2009;119:2726-2734.)

Functional (secondary) TR of severe degree is present in about 30% of patients with severe mitral regurgitation. If not surgically treated, the TR tends to progress, even after adequate treatment of the left-sided valvular lesion. Severe secondary TR is associated with impaired survival and worsening heart failure. Among patients with heart failure, approximately one-third have moderate or severe TR, which is a predictor of reduced long-term survival and even more so when pulmonary hypertension is present.

Appropriate timing of intervention is crucial to avoid irreversible RV damage and organ failure with subsequent increased surgical risk, but there is debate on the appropriateness of correction of less than severe TR. , In patients with mild or moderate functional TR undergoing operation for severe mitral regurgitation, a recent randomized trial demonstrated that concomitant tricuspid anuloplasty during mitral valve surgery reduces the composite endpoint of TR progression, TV reoperation, and all-cause death, but the reduction was primarily due to reduced TR progression. An unexpected disadvantage of concomitant TV repair in the study patients was a fivefold increase in the need for permanent pacemaker implantation compared with patients having mitral valve repair alone. Functional TR and its risk factors are further discussed in Chapter 11 .

Preoperative echocardiography at initial operation is advisable to detect not only morphology and severity of TR but also tricuspid anular size. Once the anulus dilates, its diameter does not usually normalize without surgical correction. The importance of a dilated tricuspid anulus in the genesis of severe TR is underscored by the study of Dreyfus and colleagues, who reported a dramatic reduction in late progression of TR by routinely performing tricuspid anuloplasty during surgery for left-sided valve lesions if the tricuspid anulus was greater than twice normal size. In the presence of tricuspid anular dilation, additional tricuspid anuloplasty during concomitant left-sided cardiac surgery does not increase operative risk but promotes reverse remodeling of the right ventricle and improves the functional class, even in the absence of severe TR. , However, the threshold at which tricuspid anular diameter enlargement should prompt repair is unsettled. Hasan and colleagues reported that among patients who did not have correction of moderate or less preoperative TR, risk of progression to severe TR was not associated with baseline tricuspid anular diameter when analyzed either as a categorical measurement of <4 or ≥4 cm or as a continuous variable. McCarthy and colleagues reported that a significant increase in late TR progression was not apparent until the preoperative anulus diameter reached 4.5 cm.

Technique of operation

Tricuspid valve anuloplasty

Several techniques can be used to address TR due to tricuspid anular dilation. All of them aim to provide long-term anular stabilization and preserve leaflet mobility and coaptation. Because isolated TV disease is rare, the following operative technique describes tricuspid repair with accompanying left-sided valve disease. Bicaval venous cannulation is routinely used. After the mitral procedure is completed, the right atrium is opened with the usual oblique incision ( Fig. 13.5 ). The tricuspid procedure can be performed with or without cardioplegic arrest. Once a possible intracardiac shunt (e.g., patent foramen ovale) has been ruled out or repaired, the tricuspid procedure may be performed on the beating, perfused heart during rewarming of the patient after the left-sided procedure, with suction on the aortic vent needle after the left heart has been carefully de-aired. To improve visualization and facilitate the beating-heart tricuspid procedure, a flexible cardiotomy suction device is inserted to remove blood that drains from the coronary sinus. Once the valve procedure has been performed, a water test is used to assess valve competency. However, water may quickly drain out of the right ventricle before achieving closure of the valve leaflets; therefore, interpretation of this test may be challenging, and after discontinuing cardiopulmonary bypass but prior to decannulation, TEE is used to assess valve competency and RV function. The presence of residual moderate or severe TR is an indication for a second repair attempt or valve replacement. New signs of RV dysfunction, particularly with inferior segmental wall motion abnormalities, may signify compromise of the right coronary artery, a rare but well-described complication of TV surgery.

• Figure 13.5

Tricuspid ring anuloplasty. (A) Exposure is through usual oblique right atriotomy. Venous cannulas are inserted directly into superior and inferior venae cava (for alternatives, see Chapter 2 ). (B) Stay sutures provide excellent exposure (alternatively, an atrial retractor may be used). The surgeon identifies anteroseptal TV commissure, membranous part of AV septum, and coronary sinus orifice and can then mentally visualize location of the AV node and penetrating portion of the bundle of His. Using appropriate sizers, notched at points corresponding to anteroseptal and posteroseptal commissures at both ends of the septal tricuspid leaflet, a proper-sized tricuspid anuloplasty ring is selected. (C) The first stitch, of No. 2-0 or 3-0 polyester, is positioned exactly at the midpoint of the septal leaflet anulus, and only two more mattress stitches are needed for the septal portion of the ring. Small pledgets may be used on these mattress sutures. These and all other sutures are passed first through host tissue and then through the cloth of the undersurface of the ring, just as in suturing the ring for mitral anuloplasty (see Chapter 11 ). (D) Five or six mattress stitches are needed in the portion of the anulus to be plicated, which is adjacent to the posterior leaflet, and these are passed through the cloth of the ring close together (marking stitches are present on the ring cloth to guide the surgeon). The remainder of the ring, corresponding to about half its circumference, is attached to the anulus at the base of the anterior cusp with, at most, four fairly widely spaced mattress sutures. The ring is lowered into position along the sutures and the sutures tied, with great care taken not to pull upward strongly on them, lest they tear out. In some cases, the anuloplasty ring can be secured in place with three or four interrupted mattress sutures along the septal leaflet and then with continuous sutures for the remainder.

Anuloplasty ring technique.

When an anuloplasty is performed using a ring, the size of the ring is determined with a sizer that fits the length of the septal leaflet (intertrigonal distance) and/or the size of the anterior leaflet. It is not advisable to undersize the rings in the belief that it will be more effective because it distorts and narrows the valve orifice and may subsequently lead to ring dehiscence. TV anuloplasty rings generally range between 28 and 34 mm in size. Anuloplasty rings are designed with a gap in the segment that overlies the AV node so that the conduction tissue is not compromised.

Rings correct TR by returning the anulus to its normal size by plicating that portion at the base of the anterior and posterior leaflets. Flexible rings and bands allow the anulus to move throughout the cardiac cycle and may thereby reduce stresses on the repair. Although both rigid and flexible anuloplasty rings/bands provide acceptable early TV repair results, the use of a rigid ring may increase late risk of ring dehiscence. Because tissues around the TV are usually tenuous, sutures must take adequate bites, beginning in the atrial wall and passing into the deeper part of the anulus itself, while carefully avoiding leaflet tissue. The surgeon must also be cognizant of the location and course of the right coronary artery to avoid inadvertent suture ligation or distortion.

Bicuspidization technique.

An alternative technique to an anuloplasty ring is to shorten the circumference of the tricuspid anulus by simply excluding the part to which the posterior leaflet is attached. To accomplish this, a 2-0 or 3-0 polyester suture is passed through the anulus at the anteroposterior commissure, then at the center of the posterior leaflet, and then through the anulus at the posteroseptal commissure. The suture is tied snugly, and a second one is placed for reinforcement. Pledgeted mattress sutures also may be used. A further modification that incorporates a flexible strip into the posterior leaflet anuloplasty has also been reported. The bicuspidization technique has been used with decreasing frequency over time due to the very satisfactory results achieved with anuloplasty devices.

De vega technique.

The De Vega technique has the advantages of simplicity and low cost. In this technique, a 0 polypropylene suture is passed in a clockwise direction as a running stitch into the junction of the anulus and RV wall, from the commissure between the septal and anterior leaflet to a point opposite the os of the coronary sinus ( Fig. 13.6 ). The same suture is then reversed and passed in a counterclockwise direction slightly peripherally to the first stitch back to the starting point. Separate pledgets of polyester felt are incorporated in the suture at each end to prevent its pulling through the tissues. The suture is tightened until the orifice will admit an appropriate sizer (24 to 28 mm) and is then tied. When properly performed, the De Vega suture anuloplasty is as effective and durable as the ring technique.

• Figure 13.6

De Vega anuloplasty. (A) The classic De Vega anuloplasty is accomplished using a double-armed No. 2-0 braided polyester suture or a 0 polypropylene suture. It is designed to narrow the tricuspid anulus at the base of the anterior and posterior leaflets, avoiding the area of the penetrating bundle of His and AV membranous septum. One arm and then the other arm of the suture pass into the tricuspid anulus, taking 8 to 10 fairly deep bites. (B) Suture is tied over a felt pledget, producing a purse-string effect and narrowing the orifice to admit a 24- to 28-mm sizer. (C) Often a sufficient repair can be done by narrowing the anulus only in the lateral half of the anterior leaflet and the base of the posterior leaflet.

Other supplemental techniques.

Many of the techniques of mitral valve reconstruction have been applied to repair of TR, particularly in the setting of congenital heart disease. Partial or complete closure of accessory commissures, implanting artificial chordae, Alfieri edge-to-edge technique, and pericardial leaflet augmentation have all been described.

Tricuspid valve replacement

When TV replacement is required, the leaflets are excised, and a 3- to 5-mm fringe of leaflet tissue is left on the anulus ( Fig. 13.7 ). Alternatively, the septal leaflet may be left in situ. Interrupted pledgeted mattress sutures are placed in the remaining skirt of leaflet tissue along the area occupied by the septal leaflet to avoid damaging the AV node and the bundle of His. Either a continuous polypropylene suture or interrupted pledgeted mattress sutures may be used for the remainder of the insertion. Alternatively, simple interrupted sutures may be used throughout.

• Figure 13.7

TV replacement. (A) Exposure is as for repair. All three leaflets of the TV are excised, leaving a cuff at the base of the septal leaflet 5 to 8 mm wide. Alternatively, the septal leaflet may be left in situ. (B) Starting at the midpoint of the septal leaflet cuff, interrupted horizontal mattress sutures buttressed with felt pledgets are placed first into remaining valve tissue and then through the sewing ring of the replacement device. (C) After placing four to five interrupted mattress sutures, remainder of the insertion might be completed using a continuous suture technique. Interrupted sutures can also be used circumferentially. Bites may be through the anulus, mindful that the right coronary artery lies deep to the anulus anteriorly. AV, Atrioventricular.

Tricuspid valve excision

In intravenous drug users or patients with multiple recurrent episodes of TV endocarditis, the three leaflets and their chordae tendineae can be excised to avoid implantation of prosthetic material and reduce the risk of recurrent infection. However, postoperative recovery and late cardiac performance are compromised by the resulting torrential TR. In addition, later valve replacement is more difficult.

Partial tricuspid valve replacement with cryopreserved tricuspid valve allograft

Partial replacement of the TV with a cryopreserved allograft is an attractive option for severe TR caused by endocarditis, because allografts are thought to result in a lower risk of recurrent infection. Shrestha and colleagues from Brisbane, Australia, reported favorable outcomes in 13 patients (three late reoperations) using TV allografts for tricuspid endocarditis.

Special features of postoperative care

Perioperative vasoplegia and RV dysfunction are relatively common early postoperative complications following TV surgery. Advanced cardiovascular monitoring with a Swan-Ganz catheter and bedside echocardiography is helpful in guiding vasopressor and inotropic therapy, as well as volume management. In the case of refractory cardiogenic shock, mechanical circulatory support is an option to bridge the initial postoperative hemodynamic instability. Fluid retention is prominent among patients with TV disease and frequently worsens in the early postoperative period. Characteristically, postoperative care requires aggressive use of diuretic agents or even dialysis to optimize volume management.

Biological prostheses are usually preferred in the tricuspid position, particularly in intravenous drug use patients in whom lifelong anticoagulation may be problematic. Additionally, reoperation rates are similar for biological and mechanical prostheses in the tricuspid position in general population patients. A mechanical valve may be more appropriate if there is an additional mechanical prosthesis in either the mitral or aortic position. Warfarin administration is begun as soon as chest tubes and central catheters have been removed in such patients (see “Anesthesia and Postoperative Care” in Chapter 4 ).

Because of the risk of complete heart block during the hospital stay, electrocardiographic monitoring should be continued until a stable rhythm is established at an adequate heart rate. In addition, an epicardial lead may be placed prophylactically at the time of surgery in patients undergoing a TV replacement procedure.

Results

Tricuspid valve anuloplasty

Symptom relief.

Assessing the clinical benefit of tricuspid anuloplasty in the setting of concomitant mitral valve surgery is confounded by the favorable impact of relieving mitral valve stenosis or regurgitation. The symptomatic benefit can be more directly evaluated in patients undergoing isolated TV surgery, but these patients are less common. In a study of 60 patients with flail TV leaflets, symptomatic improvement occurred in 88% of those who underwent TV repair or replacement.

Survival.

Because tricuspid anuloplasty is uncommonly performed as an isolated procedure, its effect on early and late survival is difficult to assess directly. In patients with isolated TR from trauma or endocarditis, reported surgical mortality is low, with a 5-year reported survival of 77%. , Among patients with TV endocarditis, long-term survival is slightly lower. Pfannmueller and colleagues reported a 63.9% survival at 5 years in patients with infective endocarditis who underwent TV repair. In combined operations including tricuspid anuloplasty, early mortality can be similar to that of operations in which tricuspid anuloplasty was not required. , Cardiothoracic Surgical Trials Network (CTSN) investigators reported a similar 2-year survival of patients undergoing combined mitral and TV surgery compared to those who underwent mitral valve surgery alone for degenerative mitral valve disease and mild to moderate TR. As mentioned previously, concomitant TV surgery was associated with a higher need for postoperative pacemaker implantation.

End-organ damage from long-standing right heart failure increases the risk of surgery. When right heart failure is severe enough to cause liver damage, the Model for End-Stage Liver Disease (MELD) score has been applied to predict operative mortality in combined procedures that include tricuspid anuloplasty. , High MELD scores are strongly predictive of increased hospital mortality. Intermediate-term survival may also be compromised by persistence of important RV dysfunction that often accompanies severe TR (see “ Mitral Valve Disease with or without Tricuspid Valve Disease ” in Chapter 11 ). An analysis by Singh and colleagues indicated that anuloplasty is an independent predictor of better 10-year survival compared with TV replacement for organic disease. Severe pulmonary hypertension is a relative contraindication for isolated TV surgery because it is associated with worse outcomes. However, some of these patients may still benefit from TV surgery. The pulmonary pressure alone is an inadequate predictor of outcomes following TV surgery, however, and the aortopulmonary pressure quotient has been reported to be a better predictor. Regardless of the degree of pulmonary hypertension, patients undergoing isolated TV surgery with an aortopulmonary pressure quotient ≤4 have a superior 5-year survival.

Recurrent tricuspid regurgitation and freedom from reoperation.

Tricuspid anuloplasty results in early valvular competence in most patients. Ejiofor and colleagues reported a 5-year freedom from recurrent TR of 65% in patients undergoing isolated TV repair. Several risk factors have been identified for recurrent TR after repair. Recurrence is more likely when mitral disease progresses or severe pulmonary hypertension persists (see “ Mitral Valve Disease with or without Tricuspid Valve Disease ” in Chapter 11 ). Because persisting severe TR appears to be a marker for underlying advanced myocardial and valvular heart disease, reoperations for recurrent TR are generally high-risk procedures, with hospital mortality rates being reported of up to 35%. However, high-volume centers have recently reported much lower perioperative mortality rates for isolated redo TV surgery, even rates as low as 5%. Tethering of the TV leaflets is a risk factor for early recurrent TR, and depressed right or left ventricular function predicts later TR recurrence. , Other factors increasing the risk of late TR recurrence include higher preoperative TR grade, depressed left ventricular function, and permanent pacing leads through the TV. In a study of pacemaker leads remaining across the TV following anuloplasty repair, 42% of patients had severe TR at 5 years, twice the prevalence of those without such leads. , The relationship between anuloplasty technique and outcome is discussed in the text that follows (see “ Selection of Anuloplasty Technique and Choice of Device ”).

Functional status.

Functional status as assessed by NYHA functional class is usually improved by tricuspid anuloplasty. The 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease recommends TV surgery, preferably tricuspid repair, in selected patients with TR to improve quality of life and symptoms with a class 2a recommendation.

Tricuspid valve replacement

Survival.

Early mortality for TV replacement with or without double or triple valve surgery is currently about 2% to 10%, less than in earlier years, and 18% for reoperative TV replacement with or without double or triple valve surgery (see “ Risk Factors for Premature Death after Tricuspid Valve Surgery ” later in this chapter). However, mortality may exceed 25% in patients in NYHA class III or IV symptoms or those with complex congenital heart disease. A propensity analysis indicated no important differences in early and late survival among patients undergoing TV repair versus replacement. Thus, the surgeon should perform TV replacement when the anatomic substrate is suboptimal for repair. No survival difference has been demonstrated between mechanical and bioprosthetic TV replacement procedures. ,

Survival at 10 years is approximately 55% to 60% post-TV replacement, including hospital deaths. Most of these patients have multivalvular disease, and TV failure is seldom the dominant factor in late death. Predictors of late mortality after TV replacement include older age at operation, poor left or right ventricular function, endocarditis, preoperative stroke or renal failure, and concomitant mitral valve surgery.

Mode of premature late death.

Following TV surgery, most late deaths are related to advanced RV dysfunction or arrhythmias, factors that are frequently present during the original TV operation. Endocarditis and stroke are uncommon modes of death, as are recurrent moderate or severe tricuspid stenosis or regurgitation resulting from malfunction of the replacement devices or failed anuloplasty. Thus, among 284 patients followed over nearly 10 years (combined data from GLH-UAB), prevalence of these complications was similar after either TV repair or replacement and accounted for 9 (11%; CL 8%–16%) of the late deaths, or 3.2% of the entire group (CL 2%–5%).

Complete heart block.

Early postoperative heart block is not uncommon post-TV replacement surgery; therefore, prophylactic placement of an epicardial lead may be employed at the time of surgery. Alternatively, temporary ventricular pacing wires can be used early after operation with the plan for transvenous insertion of a ventricular lead through the coronary sinus if permanent pacing is necessary. Late complete heart block occasionally develops after TV replacement, usually in patients with concomitant mitral valve replacement. , This association is undoubtedly related to the position of the AV node between the two replacement devices. In all, approximately 10% to 14% of patients undergoing both tricuspid and mitral valve replacement require insertion of a pacemaker late postoperatively because of heart block, and up to 10 years postoperatively, the prevalence is 25%. Late heart block is rare among patients undergoing TV replacement as an isolated procedure. Late development of complete heart block is also uncommon after tricuspid anuloplasty.

Thromboembolism.

Pulmonary embolization is a rare complication of TV surgery. Only 1 of 103 patients had probable large pulmonary emboli on follow-up, and the origin of that embolus was uncertain.

Valve thrombosis.

After TV replacement, valve thrombosis may occur, more often of mechanical devices than of bioprostheses. The older types of mechanical prostheses (Smelloff-Cutter, Bjork-Shiley) apparently had a greater risk than present bileaflet valves. , The linearized thrombosis rate in Van Nooten’s series of 146 tricuspid replacements was approximately 1% per patient-year.

In an Italian study of 43 patients undergoing TV replacement with a variety of mechanical prostheses, actuarial freedom from valve thrombosis was greater than 80% at 10 years. Initial thrombolytic treatment may relieve obstruction in many cases. Hurrell and colleagues have reviewed the efficacy of thrombolytic therapy for all valve positions, and this approach seems particularly effective for prostheses in the tricuspid position ( Table 13.1 ). Currently, thrombolysis is considered the first line of therapy for TV thrombosis, in contrast to left-sided valve thrombosis, in which risk of systemic and cerebral emboli is increased.

TABLE 13.1

Efficacy of Thrombolytic Therapy and Recurrence of Valve Obstruction, Stratified by Valve Position

From Hurrell DG, Schaff HV, Tajik AJ. Thrombolytic therapy for obstruction of mechanical prosthetic valves. Mayo Clin Proc. 1996;71:605.

THERAPEUTIC SUCCESS RECURRENCE OF OBSTRUCTION
Position Total n n % n (Total n ) % of n
Mitral 122 99 81 21 (114) 18
Aortic 51 44 86 8 (49) 16
Tricuspid 28 24 86 5 (26) 19
Pulmonary 6 6 100 1 (6) 17
Total 207 173 84 35 (195) 18
P value .6 .99

Overall success of thrombolytic therapy was 84%. Success for right-sided valves (88%) was similar to that for left-sided valves (83%; P = 0.4).

Functional status.

Late functional status of patients undergoing TV surgery is influenced more by the preexisting RV dysfunction and the multivalvular nature of most of the procedures than by the tricuspid repair or replacement itself. Nonetheless, most patients are considerably improved by the surgical procedure. Thus, in the GLH-UAB follow-up group, 42% of 103 patients were in NYHA class I late postoperatively. This is more impressive when it is realized that of these, 34 patients presented with preoperative cardiogenic shock or hemodynamic instability requiring emergency operation, 62 patients were in class IV heart failure, and 6 patients were in class III heart failure. Less than 15% were in class IV late postoperatively.

Symptoms of systemic venous hypertension.

Most patients remain free of systemic venous hypertension late postoperatively. However, peripheral edema and hepatomegaly, with or without ascites, can occur at follow-up. These symptoms could be the result of functional or organic obstruction of the tricuspid replacement device, residual left-sided cardiac failure with or without left-sided valvular disease, or important residual pulmonary hypertension (high pulmonary vascular resistance) or residual RV dysfunction.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Apr 21, 2026 | Posted by in CARDIAC SURGERY | Comments Off on Tricuspid valve disease

Full access? Get Clinical Tree

Get Clinical Tree app for offline access